XML 29 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Note 9 - Stock-based Compensation Plans and Warrants
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
9
– STOCK-BASED COMPENSATION PLANS AND WARRANTS
 
The Company has issued options and has granted stock awards pursuant to its
2009
Equity Incentive Plan and
2014
Equity Incentive Plan, as described below.
 
2009
Equity Incentive Plan
 
The
2009
Equity Incentive Plan was approved by stockholders at the
2009
Annual Meeting. The plan provides for the grant and issuance of up to
850,000
shares and options to the Company’s employees and consultants. The plan became effective when the Company filed a registration statement on Form S-
8
on
December 18, 2009.
All options issued under the
2009
Equity Incentive Plan have a
ten
-year term with vesting periods ranging from issuance date to
24
months.
 
2014
Equity Incentive Plan
 
The
2014
Equity Incentive Plan was approved by stockholders at the
June 10, 2014
Annual Meeting. The plan provides for the grant and issuance of up to
675,000
shares and options to the Company’s employees, directors and consultants. Upon approval of the
2014
Equity Incentive Plan, all shares of common stock that remained available for award under the
2009
Equity Incentive Plan were cancelled. Following registration of the
2014
Plan on Form S-
8,
the Company entered into revised employment agreements with certain senior management that provided for the issuance of up to
162,500
Restricted Stock Units (“RSU’s”) during the period
July 1, 2014
through
December 31, 2016,
and the issuance of up to
200,000
RSU’s in connection with obtaining construction financing for the Water Project (“Milestone RSUs”). The Milestone RSUs vested in
June 2017,
and the Company recorded stock compensation expense of
$1.7
million during the year ended
December 31, 2017,
to reflect the issuance of these shares.
 
Under the
2014
Equity Incentive Plan, each outside director receives
$30,000
of cash compensation and receives a deferred stock award consisting of shares of the Company’s common stock with a value equal to
$20,000
on
June 30
of each year. The award accrues on a quarterly basis, with
$7,500
of cash compensation and
$5,000
of stock earned for each fiscal quarter in which a director serves. The deferred stock award vests automatically on
January 31
in the year following the award date.
 
All options that have been issued under the above plans have been issued to officers, employees and consultants of the Company. In
December 2018,
unexercised options to purchase
15,000
shares were forfeited under the
2009
Equity Incentive Plan. As of
December 31, 2018,
options to purchase
492,500
shares were unexercised and outstanding on
December 31, 2018,
under the
2009
and
2014
equity incentive plans.
 
For consultants of the Company, the fair value of each option granted under the
2009
Equity Incentive Plan is estimated at each reporting period using the Black-Scholes option pricing model and recorded as a liability until the award is settled.
 
For officers and employees of the Company, the fair value of each option granted under the plans was estimated on the date of grant using the Black-Scholes option pricing model.
 
The risk-free interest rate is assumed to be equal to the yield of a U.S. Treasury bond of comparable maturity, as published in the Federal Reserve Statistical Release for the relevant date. The expected life estimate is based on an analysis of the employees receiving option grants and the expected behavior of each employee. The expected volatility is derived from an analysis of the historical volatility of the trading price per share of the Company’s common stock on the NASDAQ Global Market. The Company does
not
anticipate that it will pay dividends to common stockholders in the future.
 
The Company recognized
no
stock-option-related compensation costs for the years ended
December 31, 2018
and
2017
relating to these options.
No
stock options were exercised during
2018.
 
No
options were granted in
2018
and
2017.
A summary of option activity under the plans as of
December 31, 2018,
and changes during the year ended
December 31, 2017
are presented below:
 
   
 
 
 
 
 
 
 
 
Average
   
Aggregate
 
   
 
 
 
 
Weighted-
   
Remaining
   
Intrinsic
 
   
 
 
 
 
Average
   
Contractual
   
Value
 
   
Shares
 
 
Exercise Price
   
Term
   
($000’s)
 
                                 
Outstanding at January 1, 2017
   
507,500
 
  $
11.66
     
3.3
    $
3,934
 
Granted
   
-
 
  $
-
     
 
     
 
 
Forfeited, Expired or canceled
   
-
 
  $
-
     
 
    $
-
 
Exercised
   
-
 
  $
-
     
 
     
 
 
                                 
Outstanding at December 31, 2017
   
507,500
 
  $
11.66
     
2.3
    $
3,934
 
Granted
   
-
 
  $
-
     
 
     
 
 
Forfeited, Expired or canceled
   
15,000
 
  $
11.75
     
 
    $
100
 
Exercised
   
-
 
  $
-
     
 
     
 
 
                                 
Outstanding at December 31, 2018
   
492,500
 (a)
  $
11.66
     
1.3
    $
3,834
 
                                 
Options exercisable at December 31, 2018
   
492,500
 
  $
11.66
     
1.3
    $
3,834
 
                                 
Weighted-average years of remaining contractual life of options outstanding at December 31, 2018
   
1.3
 
   
 
     
 
     
 
 
 
 
(a)
Exercise prices vary from
$9.88
to
$12.51,
and expiration dates vary from
January 2020
to
December 2021.
 
Stock Awards to Directors, Officers, Consultants and Employees
 
The Company has granted stock awards pursuant to its
2009
Equity Incentive Plan and
2014
Equity Incentive Plan.
 
Of the total
850,000
shares reserved under the
2009
Equity Incentive Plan,
297,265
shares were issued as share grants and
507,500
were issued as options. Upon approval of the
2014
Equity Incentive Plan in
June 2014,
45,235
shares remaining available for award under the
2009
Equity Incentive Plan were cancelled.
 
Of the total
675,000
shares reserved under the
2014
Equity Incentive Plan,
641,668
shares have been awarded to the Company’s directors, consultants and employees. Of the
641,668
shares awarded,
10,224
shares were awarded for service during the plan year ended
June 30, 2018,
became effective on that date and vested on
January 31, 2019.
 
The accompanying consolidated statements of operations and comprehensive loss include approximately
$473,000
and
$2,304,000
of stock-based compensation expense related to stock awards in the years ended
December 31, 2018
and
2017,
respectively.
 
A summary of stock awards activity under the plans during the years ended
December 31, 2017
and
2018
is presented below:
 
   
 
 
 
 
Weighted-
 
   
 
 
 
 
Average
 
   
 
 
 
 
Grant-date
 
   
Shares
   
Fair Value
 
                 
                 
Nonvested at December 31, 2016
   
17,365
    $
5.76
 
Granted
   
231,762
    $
13.22
 
Forfeited or canceled
   
-
    $
-
 
Vested
   
(240,433
)
  $
12.66
 
                 
Nonvested at December 31, 2017
   
8,694
    $
13.81
 
Granted
   
35,720
    $
12.67
 
Forfeited or canceled
   
-
    $
-
 
Vested
   
(34,190
)
  $
12.94
 
                 
Nonvested at December 31, 2018
   
10,224
    $
12.71